Trial Profile
Outpatient treatment of osteomyelitis with telavancin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2018
Price :
$35
*
At a glance
- Drugs Telavancin (Primary)
- Indications Osteomyelitis
- Focus Adverse reactions; Therapeutic Use
- 07 Mar 2018 New trial record